Positron Corporation Sells NeuSight PET-CT Scanner
![Positron Corporation Sells NeuSight PET-CT Scanner](https://investorshangout.com/images/blog/ihnews-Positron%20Corporation%20Sells%20NeuSight%20PET-CT%20Scanner.jpg)
Positron Corporation Announces Sale of NeuSight PET-CT Scanner
Positron Corporation (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, is pleased to announce the sale of Positron’s NeuSight PET-CT 64 slice scanner to a recognized leader in preventive, invasive, and interventional cardiovascular services.
Innovative Features of NeuSight PET-CT Scanner
The NeuSight PET-CT was designed to revolutionize cardiac PET imaging, offering unparalleled value and empowering practices with cutting-edge technology at an unmatched price. This top-performing scanner has achieved over 500 installations worldwide. An important aspect of the system's design is patient comfort, featuring a spacious 72cm gantry, complemented by high-sensitivity acquisition technology that ensures safety with minimal radiation exposure for both patients and technicians. The NeuSight PET-CT scanner boasts the smallest footprint and lightest weight of any PET-CT 64 slice system available in the industry.
Efficiency in Clinical Applications
The NeuSight PET-CT scanner is an innovative and cost-effective PET-CT system, making it ideally suited for both cardiology and oncology clinical studies. It provides superior data acquisition capabilities, alongside advanced identification technology for enhanced scanning speed and accuracy. This system facilitates anatomic and functional imaging with qualified designs and advanced technology, catering to a variety of molecular imaging functions for heart, tumor, and brain imaging studies.
Statements from Leadership
Adel Abdullah, President of Positron, expressed enthusiasm, stating, “We are thrilled to have our first NeuSight PET-CT with such an esteemed cardiovascular physician and practice, dedicated to delivering expert cardiac care. We look forward to supporting their needs as they expand their practice in the future.”
Mr. Abdullah further noted, “Since we introduced our NeuSight PET-CT, we have been very pleased with the enthusiasm from many nuclear cardiologists interested in our PET-CT technology and its unmatched price point in the imaging market. The NeuSight PET-CT is the perfect solution for advanced nuclear cardiac studies, and we look forward to continuing to deliver this unique combination of technology, services, and value to practices and hospitals for years to come.”
About Positron Corporation
Positron Corporation is a medical technology company that co-develops, manufactures, and sells state-of-the-art PET and PET-CT imaging systems and clinical services to nuclear medicine healthcare providers across North America. Specializing in cardiac Positron Emission Tomography (PET) imaging, Positron’s innovative technologies and clinical services empower healthcare providers to accurately diagnose coronary artery disease, leading to improved patient outcomes while maintaining cost-effective practices.
Future Developments and Market Position
Positron's Attrius PET and NeuSight PET-CT imaging systems represent significant advantages that facilitate the widespread adoption of cardiac PET and contribute to the growth of the nuclear imaging market. The Company is set to enhance its offerings with the introduction of a state-of-the-art PET-CT 4D molecular imaging device known as the Affinity PET-CT 4D 64-Slice. This new addition will enable nuclear cardiologists to fully harness the capabilities of molecular imaging and nuclear medicine. Furthermore, Positron’s PET-CT systems position the Company to meet the burgeoning demands of the oncology imaging segment within nuclear medicine.
Commitment to Advancing Technology
Positron is dedicated to expanding the cardiac and oncology PET modalities by delivering the best technology and value to imaging specialists. The company is committed to advancing its technology through collaboration with its co-developer, supplier, and R&D venture with Shenyang Intelligent Nuclear Technology Co., a subsidiary of Neusoft Medical Systems.
Frequently Asked Questions
What is the NeuSight PET-CT scanner?
The NeuSight PET-CT scanner is a state-of-the-art imaging device designed for cardiac and oncology studies, known for its compact size and advanced data acquisition technology.
Who is Positron Corporation?
Positron Corporation is a medical technology company specializing in the development and sale of PET and PET-CT imaging systems for nuclear medicine healthcare providers.
What advantages does the NeuSight PET-CT offer?
The NeuSight PET-CT offers enhanced patient comfort, minimal radiation exposure, superior scanning speed, and accuracy, making it ideal for various clinical applications.
How many installations has the NeuSight scanner achieved?
The NeuSight PET-CT scanner has achieved over 500 installations worldwide, demonstrating its acceptance and performance in the market.
What is Positron's future direction?
Positron aims to advance its technologies and expand its product offerings, including the forthcoming Affinity PET-CT 4D 64-Slice device, to meet the growing demands of cardiac and oncology imaging.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Asia Pacific Wire & Cable Corporation Limited Q2 2024 Results
- International Petroleum Corporation Announces Share Buyback Details
- International Petroleum Corporation Announces Share Buyback Results
- Commercial National Financial Corporation Declares Dividend
- Cargotec Corporation Initiates Share Repurchase Plan
- EnWave Corporation Q3 2024 Financial Highlights
- Savaria Corporation Declares Monthly Dividend
- Repligen Corporation's Upcoming Presentation at Healthcare Conference
- Balchem Corporation to Showcase Innovations at Conference
- Vaisala Corporation Announces Managers' Transaction Details